Specifically, CA IX was generally expressed over a greater area of the tumour than VEGF mRNA, and VEGF but not CA IX was predictive of time to recurrence and risk of stage progression in Ta/T1 disease. The gene discussed is VEGFA; the disease is neoplasm.